BRD4 and renal cell carcinoma: Furthermore, migration and invasion assays were performed, showing that Ac-YVAD-CMK ameliorated the suppression of migration and invasion caused by BRD4 deficiency or JQ1 in RCC cells (Fig. S5A–D), suggesting that BRD4 inhibition suppressed EMT progression via caspase-1-dependent pyroptosis.